Novolog Pharm-Up 1966 Ltd (NVLG) — Free Cash Flow Generation Index
Novolog Pharm-Up 1966 Ltd (NVLG) has a Free Cash Flow Generation Index of 2.41x as of September 2025. Free cash flow of ILA37.20 Million represents 2% of operating cash flow (ILA15.42 Million). Read NVLG total debt and obligations for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Novolog Pharm-Up 1966 Ltd Free Cash Flow Generation Index (2014–2024)
Historical FCF Generation Index trend for Novolog Pharm-Up 1966 Ltd across 11 annual periods. Explore capital reinvestment ratio of Novolog Pharm-Up 1966 Ltd to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Novolog Pharm-Up 1966 Ltd (2014–2024)
Year-by-year Free Cash Flow Generation Index for Novolog Pharm-Up 1966 Ltd. For the full company profile including market capitalisation, see NVLG market cap.
| Year | FCG Index | Free Cash Flow (ILA) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.63x | ILA99.78 Million | ILA158.52 Million | ILA58.74 Million | ▼ -2.4% |
| 2023 | 0.65x | ILA129.06 Million | ILA200.01 Million | ILA70.95 Million | ▲ +35.5% |
| 2022 | 0.48x | ILA63.16 Million | ILA132.65 Million | ILA69.49 Million | ▼ -24.7% |
| 2021 | 0.63x | ILA52.75 Million | ILA83.39 Million | ILA30.64 Million | ▲ +12.6% |
| 2020 | 0.56x | ILA32.87 Million | ILA58.48 Million | ILA25.61 Million | ▼ -25.4% |
| 2019 | 0.75x | ILA76.44 Million | ILA101.45 Million | ILA25.01 Million | ▲ +439.9% |
| 2018 | -0.22x | ILA-5.31 Million | ILA23.96 Million | ILA29.27 Million | ▼ -137.2% |
| 2017 | 0.60x | ILA51.48 Million | ILA86.37 Million | ILA34.89 Million | ▲ +73.5% |
| 2016 | 0.34x | ILA6.97 Million | ILA20.28 Million | ILA13.32 Million | ▼ -62.6% |
| 2015 | 0.92x | ILA128.79 Million | ILA140.29 Million | ILA11.50 Million | ▼ -6.6% |
| 2014 | 0.98x | ILA157.86 Million | ILA160.59 Million | ILA2.73 Million | — |